Secondary |
Hypertension |
26.7% |
Musculoskeletal Pain |
13.3% |
Product Used For Unknown Indication |
13.3% |
Diabetes Mellitus |
6.7% |
Fungal Skin Infection |
6.7% |
Herpes Zoster |
6.7% |
Hypercholesterolaemia |
6.7% |
Bronchitis |
3.3% |
Cutaneous Amyloidosis |
3.3% |
Dementia Alzheimer's Type |
3.3% |
Hypoglycaemia |
3.3% |
Iron Deficiency Anaemia |
3.3% |
Pyrexia |
3.3% |
|
Pyrexia |
20.0% |
Arrhythmia |
10.0% |
Blood Potassium Increased |
10.0% |
Bradycardia |
10.0% |
Electrocardiogram Qt Prolonged |
10.0% |
Liver Disorder |
10.0% |
Renal Failure Acute |
10.0% |
Shock |
10.0% |
Tubulointerstitial Nephritis |
10.0% |
|
Concomitant |
Hypertension |
20.9% |
Drug Use For Unknown Indication |
13.4% |
Rheumatoid Arthritis |
11.2% |
Product Used For Unknown Indication |
6.7% |
Prophylaxis |
5.2% |
Metastatic Renal Cell Carcinoma |
4.3% |
Osteoporosis |
4.1% |
Colorectal Cancer |
3.8% |
Diabetes Mellitus |
3.7% |
Angina Pectoris |
3.2% |
Insomnia |
3.2% |
Hypophagia |
2.9% |
Gastritis |
2.5% |
Hyperlipidaemia |
2.5% |
Type 2 Diabetes Mellitus |
2.3% |
Cerebral Infarction |
2.2% |
Hypercholesterolaemia |
2.1% |
Infection Prophylaxis |
2.1% |
Aplastic Anaemia |
1.9% |
Parkinson's Disease |
1.9% |
|
Renal Failure Acute |
9.7% |
Hepatic Function Abnormal |
7.5% |
Hiccups |
7.5% |
Respiratory Failure |
6.5% |
Rhabdomyolysis |
6.5% |
Toxic Epidermal Necrolysis |
6.5% |
Pyrexia |
5.4% |
Tremor |
5.4% |
Eosinophilic Pneumonia Acute |
4.3% |
Hypoglycaemia |
4.3% |
Lung Disorder |
4.3% |
Renal Impairment |
4.3% |
Tachycardia |
4.3% |
Vomiting |
4.3% |
Death |
3.2% |
Herpes Zoster |
3.2% |
Pneumocystis Jiroveci Pneumonia |
3.2% |
Post Procedural Haemorrhage |
3.2% |
Sensation Of Heaviness |
3.2% |
Sepsis |
3.2% |
|
Interacting |
Hypertension |
50.0% |
Nail Tinea |
25.0% |
Prophylaxis Of Nausea And Vomiting |
25.0% |
|
Drug Interaction |
66.7% |
Hypotension |
33.3% |
|